Qi, C., Liu, C., Peng, Z., Zhang, Y., Wei, J., Qiu, W., Zhang, X., Pan, H., Niu, Z., Qiu, M., Qin, Y., Fang, W., Ye, F., Li, N., Liu, T., Wang, Y., Yuan, D., Li, Z., Shen, L. (2025). Claudin18.2-specific CAR T cells (Satri-cel) versus treatment of physician's choice (TPC) for previously treated advanced gastric or gastroesophageal junction cancer (G/GEJC): Primary results from a randomized, open-label, phase II trial (CT041-ST-01).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4003